Neuroplasticity
Neuroplastic psychology relieves unexplained pain
About 40% of patients in primary care have pain or illness that cannot be explained by diagnostic tests.
Balancing innovation, entrepreneurship and patient care, with Sharief Taraman, MD
In this episode, host Hansa Bhargava, MD, discusses computer science and technology in medicine and the inequities and lack of preventive care in pediatrics with Sharief Taraman, MD.
Osteoarthritis may be 'inherently' tied to neuroplasticity
DESTIN, Fla. — “Sprouting” of new nerve endings in certain areas of the knee could be a key to understanding osteoarthritis and developing new treatments, according to a speaker at the Congress of Clinical Rheumatology East.
NIH awards Delix $320K to advance neuroplastogen for substance use disorders
Delix Therapeutics announced it has received a $320,000 grant from NIH’s National Institute on Drug Abuse to advance its novel, non-hallucinogenic neuroplastogen for treatment of substance use disorders, including opioid and stimulant use.
Dichoptic training a ‘promising’ treatment for amblyopia in adults, children
Binocular therapies that harness the plasticity of the adult visual system may improve vision in both children and adults with amblyopia, according to a review published in the European Journal of Ophthalmology.
Differences in fighter pilots’ brain connectivity may have implications for space travel
The brains of F16 fighter pilots exhibited distinct differences in motor, vestibular and multisensory processing compared with those of non-pilots and may provide valuable insight into the effects of space travel, according to research.
‘Appreciating neuroplasticity’ may be key to developing effective osteoarthritis therapies
SAN DIEGO — The key to developing effective therapies for the management of osteoarthritis may lie in appreciating neuroplasticity in patients with the disease, according to a speaker at the Congress of Clinical Rheumatology West.
Speaker: Recognizing patients’ emotional stress can reduce CV risk, improve outcomes
LOUISVILLE, Ky. — A speaker at the American Society for Preventive Cardiology Congress on CVD Prevention called on clinicians to have greater consideration for the effects of psychosocial factors on CVD and related outcomes.
Biomarker research, cannabis use tops March neurology coverage
Q&A: Neuroplasticity after stroke reveals ‘critical’ early period for rehabilitation
A longitudinal study quantifying neuroplasticity in the ipsilesional and contralesional human motor cortex following a stroke demonstrated “a period of enhanced synaptic plasticity” that was strongest about 2 weeks after the event.